ClinicalTrials.gg
Not yet recruitingNCT07358065Updated Jan 26, 2026

Clinical Application of Dynamic Multimodal Analgesia Regimen After Perianal Abscess Surgery

An interventional study of the traditional analgesic mode and Western Medicine Multimodal Analgesia in Clinical Application of Dynamic Multimodal Analgesia Regimen After Perianal Abscess Surgery, sponsored by The Affiliated Hospital of Putian University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by The Affiliated Hospital of Putian University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 249 studies in Pain, Postoperative with a site in China — 79 open to participants now, 81 under way, 3 of them phase 3. Pain, Postoperative · China.

Planned enrollment
98th of 206
135 · median 131
Started
2026
with 35 others
No phase
104 of 249
37 open now
Primary completion
2026-01
later than 31 of 80 live
Registered
211th of 249
by date

Among the 249 studies in Pain, Postoperative with a site in China, this one is the 98th largest by planned enrollment of the 206 interventional ones that give a count, is one of 36 that started in 2026, is one of 104 with no phase, reaches primary completion later than 31 of the 80 other live ones, and was the 211th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

79 of the 249 studies in Pain, Postoperative with a site in China are open now. Recruiting first, the newest first:

74 more — sign in →

All 79 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 249 studies in Pain, Postoperative with a site in China, or all of them as a file.
02

Study summary

This study aims to investigate whether the full-course multimodal analgesia regimen based on dynamic assessment (including the integrated traditional Chinese and Western medicine mode) can alleviate postoperative pain, reduce opioid dosage, and decrease the incidence of complications in patients with perianal abscess. It also intends to verify the clinical advantages of the integrated traditional Chinese and Western medicine multimodal regimen and establish a promotable standardized pain management pathway. A total of 135 eligible patients will be enrolled and divided into three groups in a 1:1:1 ratio using a single-center, prospective, randomized parallel-controlled design. The specific grouping and intervention methods are as follows: ① Control Group (Group A): Adopts the traditional analgesic mode, where NRS assessment and intervention are conducted only when the patient actively complains of pain (medication administered for scores ≥4 points) without preemptive medication. Medications refer to conventional schemes (e.g., flurbiprofen, diclofenac sodium, etc.). ② Western Medicine Multimodal Analgesia Group (Group B): Implements dynamic assessment + stepwise medication intervention + non-pharmacological auxiliary measures. Baseline NRS score is collected 24 hours before surgery; pain at rest and during activity is assessed at fixed time points after surgery; NSAIDs, opioids, and other medications are administered as needed, combined with potassium permanganate sitz bath, health education, etc. ③ Integrated Traditional Chinese and Western Medicine Multimodal Analgesia Group (Group C): Integrates characteristic traditional Chinese medicine nursing interventions (including auricular point pressing, wrist-ankle acupuncture, traditional Chinese medicine sitz bath, etc.) on the basis of Group B's intervention.

To evaluate the clinical efficacy of the dynamic multimodal analgesia regimen, this study will compare the following indicators among the three groups: NRS pain scores on postoperative days 1, 2, 3, 4, 5, as well as 2 weeks and 1 month after discharge; total postoperative analgesic consumption converted to morphine equivalent dose (MEDD); quality of life score assessed by the SF-36 scale; incidence of complications (such as urinary retention, secondary hemorrhage, etc.); sexual function recovery (assessed by the IIEF-5 scale for males and the FSFI scale for females); and patient satisfaction and compliance. The primary research hypothesis is: compared with conventional analgesia and western medicine-only multimodal analgesia, the integrated traditional Chinese and Western medicine multimodal analgesia regimen can significantly reduce patients' postoperative pain scores, decrease opioid dosage, improve quality of life and patient satisfaction, lower the incidence of complications, and enhance patients' sexual function recovery.

03

Conditions studied

  • Clinical Application of Dynamic Multimodal Analgesia Regimen After Perianal Abscess Surgery

Browse trials for

Keywords

  • Perianal Abscess
  • Postoperative Pain
  • Dynamic Assessment
  • Multimodal Analgesia
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with primary perianal abscess by clinical examinations (digital rectal examination, ultrasound, or MRI) and undergoing incision and drainage or radical surgical treatment;
  • Abscess diameter ≥ 2 cm or accompanied by obvious abscess cavity formation;
  • Patients are willing and able to participate in the pain management plan, understand the importance of pain management, and actively cooperate;
  • No severe coagulation disorders.

Exclusion criteria

Exclusion Criteria:

  • Complicated with specific infectious diseases such as Crohn's disease or tuberculosis;
  • Unclear source of postoperative pain (i.e., the patient's pain is uncertain or unrelated to the surgery);
  • Having definite , including drug allergies or inability to accept certain pain management methods adopted in the study;
  • Pregnant or lactating women;
  • Patients unable to cooperate with the study, such as those with cognitive impairment, history of mental illness, or communication difficulties;
  • Patients with long-term use of analgesic drugs and developed drug tolerance;
  • Complicated with uncontrolled cardiovascular and cerebrovascular diseases ( cardiac function Class Ⅲ-Ⅳ), liver or kidney insufficiency ( Class C or \< 30 ml/min/1.73m²), etc.;
  • Abscess secondary to rectal tumors, trauma, or iatrogenic injury;
  • Postoperative occurrence of severe complications (e.g., massive hemorrhage, sepsis) or combined infection in other parts;
  • Patients receiving only non-surgical treatments such as simple puncture and aspiration of pus.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
135 participants (estimated)

Study arms

  • Other
    Group A :Conventional Analgesia Group

    Adopts the traditional analgesic mode.

    Drug: the traditional analgesic mode

  • Other
    Group B:Western Medicine Multimodal Analgesia Group

    Implements a dynamic assessment-based full-course multimodal analgesia strategy.

    Behavioral: Western Medicine Multimodal Analgesia

  • Other
    Group C:Integrated Traditional Chinese and Western Medicine Multimodal Analgesia Group

    Integrates characteristic traditional Chinese medicine nursing interventions on the basis of western medicine multimodal analgesia.

    Behavioral: Integrated Traditional Chinese and Western Medicine Multimodal Analgesia

Interventions

  • Drugthe traditional analgesic mode

    Adopt the traditional analgesic mode: conduct NRS assessment and intervention only when the patient takes the initiative to complain of pain, without fixed assessment time points. Intervene when the pain score is ≥4 points, and no prophylactic medication is administered. Medication use refers to the conventional plan (e.g., flurbiprofen injection, diclofenac sodium capsules, etc.).

  • BehavioralWestern Medicine Multimodal Analgesia

    Collect baseline NRS score 24 hours before surgery. After surgery, assess NRS in resting and active states at fixed daily time points (e.g., 08:00, 16:00), and conduct on-demand assessment for breakthrough pain. Reassess during outpatient follow-up at 2 weeks and 1 month after discharge. 1. Stepwise medication intervention: Administer medications in a stepwise manner based on NRS score. For scores ≤3 points, prioritize non-pharmacological interventions; for scores ≥4 points, initiate NSAIDs, acetaminophen, etc.; for moderate to severe pain, administer bucinazine, pethidine, or other medications as needed. 2. Non-pharmacological auxiliary measures: Include potassium permanganate sitz bath, health education, psychological counseling, etc. 3. Dynamic adjustment: The pain management team conducts daily rounds to individually adjust the plan based on assessment results.

  • BehavioralIntegrated Traditional Chinese and Western Medicine Multimodal Analgesia

    On the basis of western medicine multimodal analgesia, integrate characteristic traditional Chinese medicine nursing interventions, such as auricular point pressing, wrist-ankle acupuncture, traditional Chinese medicine sitz bath, etc.

06

What researchers measure

Primary outcomes

  1. Postoperative pain score

    Postoperative pain score (NRS,Numeric Rating Scale): Record pain scores at rest and during activity on postoperative days 1, 2, 3, 4, 5, as well as at 2 weeks and 1 month after discharge, serving as the core assessment of the analgesic effect of the regimen.NRS,0 points indicate no pain, while 10 points represent the most severe pain.

    Time frame: From enrollment to 1 month after discharge

Secondary outcomes

  1. Secondary Efficacy Indicators

    Total postoperative analgesic consumption: Convert all analgesics to morphine equivalent dose (MEDD) for intergroup comparison to evaluate the opioid-sparing effect of the regimen.

    Time frame: From enrollment to 1 month after discharge

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Based on a strict commitment to participant privacy protection, compliance with the terms of the ethical review protocol, and adherence to the sponsoring institution's policies, IPD from this study will not be shared at this time.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Jan 2026, 0 months later.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 0 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 3, 2026
First posted
Jan 22, 2026
StartEst.
Jan 1, 2026
Primary completionEst.
Jan 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jan 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07358065
Lead sponsor
The Affiliated Hospital of Putian University
Responsible party
Hong Wu (Supervisory assistant of Scientific Research Department, The Affiliated Hospital of Putian University) — Principal investigator
First posted
Jan 22, 2026
Start date
Jan 1, 2026 (estimated)
Primary completion
Jan 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jan 26, 2026

Study contacts

Yanbing Ye
Contact
849221968@qq.com
+8613959528973

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion